Piper Jaffray analyst, Christopher Raymond, reiterated his Neutral rating on shares of Abbvie (NYSE: ABBV) after new survey data from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE